Novadip Biosciences to present data at 17th Annual Meeting of the International Federation for Adipose Therapeutics and Science

Novadip Biosciences to present data…

Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia

Minoryx Therapeutics receives Orphan Drug…

Business Alliance between Promethera Biosciences SA and MEDIPAL HOLDINGS

Notice of Business Alliance between…

EyeD Pharma CEO Melanie Mestdagt in the news

EyeD Pharma CEO Melanie Mestdagt…

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

Minoryx Therapeutics receives FDA Orphan…

Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson

Immunic, Inc. Expands Board of…

Immunic, Inc. Announces Completion of Enrollment for its Phase 2 EMPhASIS Trial of IMU-838 in Patients with Relapsing-Remitting Multiple Sclerosis

Immunic, Inc. Announces Completion of…

Minoryx: Un axe Espagne-Belgique pour sauter la barrière

Minoryx News Article: Un axe…

Minoryx Therapeutics completes enrollment in FRAMES phase 2 trial with leriglitazone in Friedreich’s Ataxia

Minoryx Therapeutics completes enrollment in…

Novadip Biosciences – Belgische ‘biotechplasticine’ redt been vijfjarige

  Novadip Press Article: Belgische…